Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer

被引:2
|
作者
Norbeck, Anna [1 ,2 ,6 ]
Asp, Mihaela [1 ,2 ]
Carlsson, Tobias [3 ]
Kannisto, Paivi [1 ,2 ]
Malander, Susanne [4 ,5 ]
机构
[1] Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden
[2] Lund Univ, Dept Clin Sci, Div Obstet & Gynecol, Lund, Sweden
[3] Reg Canc Ctr South, Lund, Region Skane, Sweden
[4] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[5] Lund Univ, Dept Clin Sci, Div Oncol, Lund, Sweden
[6] Univ Sjukhus, Kvinnoklinken Skanes, Klinikgatan 12, S-22185 Lund, Sweden
关键词
epithelial ovarian cancer; routes to diagnosis; cancer patient pathway; time to diagnosis; SYMPTOMS; SURVIVAL; OUTCOMES; DELAY; TIME; RISK; CARE;
D O I
10.2147/JMDH.S401601
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: The majority of women with ovarian cancer are diagnosed in late stages. Most women do have symptoms prior to diagnosis, sometimes several months before the diagnosis. The aim of this study was to evaluate the timeline from the first presentation of symptoms to a physician until there is a reasonable suspicion of cancer, among women diagnosed with advanced stage ovarian cancer. We wanted to investigate which symptoms were the most common and whether there are other factors affecting the time interval before the suspicion of cancer was confirmed. Patients and Methods: This was a retrospective population-based cohort study of women diagnosed with advanced ovarian cancer between January 1, 2017 and December 31, 2019 who were referred to Skane University Hospital Lund, Sweden. Data were collected from electronic medical records at Skane University Hospital. The time interval was recorded as the time from first physician consultation with predefined symptoms to the date when there was a reasonable suspicion of ovarian cancer. Data processing and statistical analysis were performed with the statistical software R. Results: Among the 249 patients included in this study, the median time interval from the first consultation to the reasonable suspicion of cancer was 24 days. The first consultation in specialized care had a 70% decrease in delay compared to primary care. Emergency consultations had a 52.2% decrease in time delay compared to planned consultations. Older age was associated with an increase in the geometric mean by 54.7%, comparing the first to the third quartile. The most common symptom was abdominal pain. Conclusion: The length of time interval from first presentation with symptoms relating to ovarian cancer to reasonable suspicion of cancer was associated with whether the consultation was in primary or specialized care, emergency or planned visit and the patient's age.
引用
收藏
页码:1239 / 1248
页数:10
相关论文
共 50 条
  • [1] Impact of age, comorbidity, and treatment on survival in elderly women with advanced epithelial ovarian cancer.
    Todd, Sarah
    Robertson, Sharon E.
    Xiong, Yin
    Extermann, Martine
    Wenham, Robert Michael
    Chon, Hye Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Multilevel Determinants of Palliative Care Referral in Women With Advanced Ovarian Cancer: A Scoping Review
    Cho, Susie
    Goff, Barbara A.
    Berry, Donna L.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (01) : e58 - e69
  • [3] Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer
    Mallen, Adrianne
    Todd, Sarah
    Robertson, Sharon E.
    Kim, Jongphil
    Sehovic, Marina
    Wenham, Robert M.
    Extermann, Martine
    Chon, Hye Sook
    GYNECOLOGIC ONCOLOGY, 2021, 161 (03) : 693 - 699
  • [4] Access to gynecologic oncologists and its impact on survival of women with epithelial ovarian cancer
    Chan, John K.
    Shin, Jacob Y.
    Husain, Amreen
    Teng, Nelson N.
    Berek, Jonathan S.
    Kapp, Daniel S.
    Osann, Kathryn
    Leiserowitz, Gary
    O'Malley, Cynthia
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S23 - S23
  • [5] Impact of race on referral for genetics assessment for women with ovarian cancer in a large health care system
    Powell, C. Bethan
    Laurent, Cecile
    Roh, Janise
    Garcia, Christine
    Kobelka, Christine
    Karlea, Audrey
    Hoodfar, Elizabeth
    Lee, Jaimie
    Kushi, Lawrence
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S181 - S181
  • [6] Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)
    Au-Yeung, George
    Webb, Penelope M.
    DeFazio, Anna
    Fereday, Sian
    Bressel, Mathias
    Mileshkin, Linda
    GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 16 - 22
  • [7] The impact of epithelial ovarian cancer diagnosis on women's life: a qualitative study
    Mangone, L.
    Mandato, V. D.
    Gandolfi, R.
    Tromellini, C.
    Abrate, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (01) : 32 - 38
  • [8] Genetic referral of women at risk for hereditary breast and ovarian cancer
    Powell, C. B.
    Littell, R. D.
    Sinclair, F.
    Hoodfar, E.
    Lovell, N.
    Pressman, A.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 434 - 435
  • [9] Impact of ovarian cancer perceived by women
    Howell, D
    Fitch, MI
    Deane, KA
    CANCER NURSING, 2003, 26 (01) : 1 - 9
  • [10] Age at onset of ovarian cancer in women with a strong family history of ovarian cancer
    Goldberg, JM
    Piver, MS
    Jishi, MF
    Blumenson, L
    GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 3 - 9